应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CALA Calithera Biosciences, Inc.
盘后交易 03-13 14:35:55 EDT 延时
资讯
新帖
简况
美国OTC市场Calithera Biosciences Inc盘中异动 快速拉升354.55%
市场透视 · 01-28
美国OTC市场Calithera Biosciences Inc盘中异动 快速拉升354.55%
美国OTC市场Calithera Biosciences Inc股价上涨29.87% 市值涨1.46万美元
市场透视 · 2024-12-03
美国OTC市场Calithera Biosciences Inc股价上涨29.87% 市值涨1.46万美元
美国OTC市场Calithera Biosciences Inc盘中异动 早盘急速跳水40.00%报0.006美元
市场透视 · 2024-10-25
美国OTC市场Calithera Biosciences Inc盘中异动 早盘急速跳水40.00%报0.006美元
美国OTC市场Calithera Biosciences Inc盘中异动 股价大涨900.00%
市场透视 · 2024-10-23
美国OTC市场Calithera Biosciences Inc盘中异动 股价大涨900.00%
美国OTC市场Calithera Biosciences Inc盘中异动 急速拉升100.00%
市场透视 · 2024-10-18
美国OTC市场Calithera Biosciences Inc盘中异动 急速拉升100.00%
美国OTC市场Calithera Biosciences Inc股价飙升100.00% 市值涨10000美元
市场透视 · 2024-10-09
美国OTC市场Calithera Biosciences Inc股价飙升100.00% 市值涨10000美元
美国OTC市场Calithera Biosciences Inc盘中异动 股价大涨1900.00%报0.020美元
市场透视 · 2024-09-26
美国OTC市场Calithera Biosciences Inc盘中异动 股价大涨1900.00%报0.020美元
美国OTC市场Calithera Biosciences Inc(CALA.us)盘中异动 下午盘股价大跌37.50%报0.013美元
市场透视 · 2024-09-24
美国OTC市场Calithera Biosciences Inc(CALA.us)盘中异动 下午盘股价大跌37.50%报0.013美元
TechInsights:二季度中美洲和拉美洲地区智能手机出货量同比增长13.1%
智通财经 · 2024-09-20
TechInsights:二季度中美洲和拉美洲地区智能手机出货量同比增长13.1%
Counterpoint Research:上半年全球5G手机出货量同比增长20% 印度超美国成为全球第二大5G手机市场
智通财经 · 2024-09-11
Counterpoint Research:上半年全球5G手机出货量同比增长20% 印度超美国成为全球第二大5G手机市场
加载更多
公司概况
公司名称:
Calithera Biosciences, Inc.
所属市场:
EXPERT
上市日期:
--
主营业务:
Calithera Biosciences, Inc.于2010年3月9日在特拉华州成立。该公司是一家临床阶段制药公司,专注于发现和开发针对肿瘤代谢和肿瘤免疫学指标治疗癌症的新型小分子药物。肿瘤代谢和肿瘤免疫学已成为癌症药物开发前景的新领域,并在每个领域的治疗剂的近期临床成功证明可以创造出新的疗法治疗癌症病人。
发行价格:
--
{"stockData":{"symbol":"CALA","market":"US","secType":"STK","nameCN":"Calithera Biosciences, Inc.","latestPrice":0.0006,"timestamp":1741890955223,"preClose":0.0006,"halted":0,"volume":59,"delay":15,"floatShares":4827391,"shares":4872497,"eps":-7.942708,"marketStatus":"盘后交易","change":0,"latestTime":"03-13 14:35:55 EDT 延时","open":0.0006,"high":0.0006,"low":0.0006,"amount":0.005900000000000001,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-7.942708,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1741910400000},"marketStatusCode":4,"adr":0,"exchange":"EXPERT","adjPreClose":0.0006,"volumeRatio":0.588823},"requestUrl":"/m/hq/s/CALA","defaultTab":"news","newsList":[{"id":"2506517819","title":"美国OTC市场Calithera Biosciences Inc盘中异动 快速拉升354.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506517819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506517819?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:06","pubTimestamp":1738076760,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时06分,美国OTC市场Calithera Biosciences Inc股票出现波动,股价急速拉升354.55%。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中,整体跌幅为0.14%。其相关个股中,Silexion Therapeutics Corp、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Hepion Pharmaceuticals, Inc.涨幅较大,Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为3000.55%、1669.39%、546.87%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp、Transcode Therapeutics, Inc.,振幅分别为122.16%、68.95%、58.57%。美国OTC市场Calithera Biosciences Inc公司简介:Calithera Biosciences Inc是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128230600a232768b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128230600a232768b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALA","BK4139"],"gpt_icon":0},{"id":"2488603085","title":"美国OTC市场Calithera Biosciences Inc股价上涨29.87% 市值涨1.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488603085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488603085?lang=zh_cn&edition=full","pubTime":"2024-12-03 00:05","pubTimestamp":1733155501,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日00时05分,美国OTC市场Calithera Biosciences Inc股票出现波动,股价急速拉升29.87%。截至发稿,该股报0.010美元/股,成交量810股,换手率0.02%,振幅28.57%。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中,整体跌幅为0.03%。美国OTC市场Calithera Biosciences Inc公司简介:Calithera Biosciences Inc是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203000502abf02fae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203000502abf02fae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CALA"],"gpt_icon":0},{"id":"2478328149","title":"美国OTC市场Calithera Biosciences Inc盘中异动 早盘急速跳水40.00%报0.006美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478328149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2478328149?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:01","pubTimestamp":1729868463,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时01分,美国OTC市场Calithera Biosciences Inc股票出现波动,股价急速下挫40.00%。截至发稿,该股报0.006美元/股,成交量175股,换手率0.00%,振幅0.00%。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中,整体涨幅为0.79%。美国OTC市场Calithera Biosciences Inc公司简介:Calithera Biosciences Inc是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523010398e3e896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523010398e3e896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CALA"],"gpt_icon":0},{"id":"2477536225","title":"美国OTC市场Calithera Biosciences Inc盘中异动 股价大涨900.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477536225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2477536225?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:19","pubTimestamp":1729693140,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时19分,美国OTC市场Calithera Biosciences Inc股票出现波动,股价大幅上涨900.00%。截至发稿,该股报0.010美元/股,成交量448股,换手率0.01%,振幅0.00%。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中,整体跌幅为1.12%。美国OTC市场Calithera Biosciences Inc公司简介:Calithera Biosciences Inc是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322190195bd4385&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322190195bd4385&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CALA"],"gpt_icon":0},{"id":"2476243484","title":"美国OTC市场Calithera Biosciences Inc盘中异动 急速拉升100.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476243484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2476243484?lang=zh_cn&edition=full","pubTime":"2024-10-18 04:03","pubTimestamp":1729195381,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日04时03分,美国OTC市场Calithera Biosciences Inc股票出现异动,股价大幅拉升100.00%。截至发稿,该股报0.002美元/股,成交量414股,换手率0.01%,振幅0.00%。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中,整体跌幅为0.06%。美国OTC市场Calithera Biosciences Inc公司简介:Calithera Biosciences Inc是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410180403019f4b1df1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410180403019f4b1df1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALA","BK4139"],"gpt_icon":0},{"id":"2474140091","title":"美国OTC市场Calithera Biosciences Inc股价飙升100.00% 市值涨10000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474140091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2474140091?lang=zh_cn&edition=full","pubTime":"2024-10-09 03:19","pubTimestamp":1728415141,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日03时19分,美国OTC市场Calithera Biosciences Inc股票出现波动,股价急速上涨100.00%。截至发稿,该股报0.002美元/股,成交量255股,换手率0.01%,振幅0.00%。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中,整体涨幅为0.27%。美国OTC市场Calithera Biosciences Inc公司简介:Calithera Biosciences Inc是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090319019f32bcca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090319019f32bcca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CALA"],"gpt_icon":0},{"id":"2470295833","title":"美国OTC市场Calithera Biosciences Inc盘中异动 股价大涨1900.00%报0.020美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470295833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2470295833?lang=zh_cn&edition=full","pubTime":"2024-09-26 01:10","pubTimestamp":1727284201,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日01时10分,美国OTC市场Calithera Biosciences Inc股票出现波动,股价快速拉升1900.00%。截至发稿,该股报0.020美元/股,成交量1.0081万股,换手率0.21%,振幅0.00%。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中,整体跌幅为0.23%。美国OTC市场Calithera Biosciences Inc公司简介:Calithera Biosciences Inc是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926011001957d6253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926011001957d6253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALA","BK4139"],"gpt_icon":0},{"id":"2469291321","title":"美国OTC市场Calithera Biosciences Inc(CALA.us)盘中异动 下午盘股价大跌37.50%报0.013美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469291321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2469291321?lang=zh_cn&edition=full","pubTime":"2024-09-24 02:32","pubTimestamp":1727116321,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日02时32分,美国OTC市场Calithera Biosciences Inc股票出现波动,股价大幅下跌37.50%。截至发稿,该股报0.013美元/股,成交量417股,换手率0.01%,振幅37.50%。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中,整体跌幅为1.74%。美国OTC市场Calithera Biosciences Inc公司简介:Calithera Biosciences Inc是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092402320195782e58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092402320195782e58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CALA"],"gpt_icon":0},{"id":"2468989136","title":"TechInsights:二季度中美洲和拉美洲地区智能手机出货量同比增长13.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468989136","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2468989136?lang=zh_cn&edition=full","pubTime":"2024-09-20 13:49","pubTimestamp":1726811394,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,TechInsights的数据显示,2024年Q2,中美洲和拉丁美洲智能手机市场同比增长显著,达到13.1%,超过了全球智能手机市场7.6%的同比增长率。realme实现了令人瞩目的250.0%的同比增长率,而荣耀和vivo则分别实现了75.0%和50.0%的显著同比增长。TechInsights表示,CALA智能手机市场在过去四个季度中一直保持着两位数的年度增长率。因此,TechInsights建议智能手机供应商将该地区作为优先市场,并专注于国家特定的适当渠道以促进扩张。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01810","BK4139","CALA"],"gpt_icon":1},{"id":"2466866424","title":"Counterpoint Research:上半年全球5G手机出货量同比增长20% 印度超美国成为全球第二大5G手机市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2466866424","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2466866424?lang=zh_cn&edition=full","pubTime":"2024-09-11 13:43","pubTimestamp":1726033418,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,根据Counterpoint的市场监测服务最新研究,全球5G手机出货量在2024年上半年同比增长20%。印度首次超过美国成为全球第二大5G手机市场,仅次于中国。随着5G渗透到更低价位段,5G手机在整体出货量中的占比首次超过50%。苹果在全球5G手机出货量中领先,占比超过25%。苹果和三星在2024年上半年的前10名5G机型中各占五个席位,其中苹果占据了前四名。小米位居第三,印度市场是其主要驱动因素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1181818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4515","IE00B4YYXB79.USD","BK4571","IE0009G5SDU7.USD","IE00BJLML261.HKD","BK4585","IE00B1XK9C88.USD","IE000YTNTUN2.SGD","BK4139","IE00B3S45H60.SGD","BK4501","IE000ITXATA3.USD","IE00B5949003.HKD","IE00BN29S564.USD","IE00BJJMRX11.SGD","IE00B19Z8X17.USD","IE0004091025.USD","IE00B19Z8W00.USD","BK4170","CALA","IE0004445015.USD","IE00BBT3K403.USD","BK4566","IE00BKVL7J92.USD","BK4574","BK4588","BK4592","IE00B4JS1V06.HKD","BK4573","IE0034235303.USD","GB00BDT5M118.USD","BK4575","BK4559","BK4576","BK4507","BK4579","BK4512","IE0009356076.USD","IE00BKDWB100.SGD","IE00BJTD4N35.SGD","IE0004445239.USD","HK0000320223.HKD","IE00B1BXHZ80.USD","IE00BJJMRY28.SGD","IE00BJTD4V19.USD","IE00B775H168.HKD","BK4550","HK0000320264.USD","IE00B775SV38.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.calithera.com","description":"Calithera Biosciences, Inc.于2010年3月9日在特拉华州成立。该公司是一家临床阶段制药公司,专注于发现和开发针对肿瘤代谢和肿瘤免疫学指标治疗癌症的新型小分子药物。肿瘤代谢和肿瘤免疫学已成为癌症药物开发前景的新领域,并在每个领域的治疗剂的近期临床成功证明可以创造出新的疗法治疗癌症病人。","exchange":"EXPERT","name":"Calithera Biosciences, Inc.","nameEN":"Calithera Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Calithera Biosciences, Inc.(CALA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Calithera Biosciences, Inc.(CALA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Calithera Biosciences, Inc.,CALA,Calithera Biosciences, Inc.股票,Calithera Biosciences, Inc.股票老虎,Calithera Biosciences, Inc.股票老虎国际,Calithera Biosciences, Inc.行情,Calithera Biosciences, Inc.股票行情,Calithera Biosciences, Inc.股价,Calithera Biosciences, Inc.股市,Calithera Biosciences, Inc.股票价格,Calithera Biosciences, Inc.股票交易,Calithera Biosciences, Inc.股票购买,Calithera Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Calithera Biosciences, Inc.(CALA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Calithera Biosciences, Inc.(CALA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}